These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 24938500)
1. Biomarkers of Alzheimer's disease risk in peripheral tissues; focus on buccal cells. François M; Leifert W; Martins R; Thomas P; Fenech M Curr Alzheimer Res; 2014; 11(6):519-31. PubMed ID: 24938500 [TBL] [Abstract][Full Text] [Related]
2. Altered cytological parameters in buccal cells from individuals with mild cognitive impairment and Alzheimer's disease. François M; Leifert W; Hecker J; Faunt J; Martins R; Thomas P; Fenech M Cytometry A; 2014 Aug; 85(8):698-708. PubMed ID: 24616437 [TBL] [Abstract][Full Text] [Related]
3. Current State of Saliva Biomarkers for Aging and Alzheimer's Disease. François M; Bull CF; Fenech MF; Leifert WR Curr Alzheimer Res; 2019; 16(1):56-66. PubMed ID: 30345919 [TBL] [Abstract][Full Text] [Related]
4. High Content, Multi-Parameter Analyses in Buccal Cells to Identify Alzheimer's Disease. François M; Fenech MF; Thomas P; Hor M; Rembach A; Martins RN; Rainey-Smith SR; Masters CL; Ames D; Rowe CC; Macaulay SL; Hill AF; Leifert WR; The Australian Imaging Biomarkers And Lifestyle Study Research Group Curr Alzheimer Res; 2016; 13(7):787-99. PubMed ID: 26975368 [TBL] [Abstract][Full Text] [Related]
6. Buccal Mucosa Biomarkers in Alzheimer's Disease. Avramouli A; Vlamos P Adv Exp Med Biol; 2020; 1195():49-56. PubMed ID: 32468458 [TBL] [Abstract][Full Text] [Related]
7. Buccal cell cytokeratin 14 identifies mild cognitive impairment and Alzheimer' s disease in the AIBL study of aging. Leifert WR; Tuli JF; Francois M; Nguyen T; Rembach A; Rumble RL; Rainey-Smith S; Martins R; Fenech MF Curr Alzheimer Res; 2015; 12(3):233-41. PubMed ID: 25731627 [TBL] [Abstract][Full Text] [Related]
8. Buccal micronucleus cytome biomarkers may be associated with Alzheimer's disease. Thomas P; Hecker J; Faunt J; Fenech M Mutagenesis; 2007 Nov; 22(6):371-9. PubMed ID: 17709794 [TBL] [Abstract][Full Text] [Related]
9. Cytologic and cytometric analysis of oral mucosa in Alzheimer's disease. de Oliveira RM; Lia EN; Guimarães RM; Bocca AL; Cavalcante Neto FF; da Silva TA Anal Quant Cytol Histol; 2008 Apr; 30(2):113-8. PubMed ID: 18561748 [TBL] [Abstract][Full Text] [Related]
10. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R; Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606 [TBL] [Abstract][Full Text] [Related]
11. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia]. Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ; Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080 [TBL] [Abstract][Full Text] [Related]
12. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease. Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738 [TBL] [Abstract][Full Text] [Related]
13. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning. Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929 [TBL] [Abstract][Full Text] [Related]
14. Imaging Techniques in Alzheimer's Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring. van Oostveen WM; de Lange ECM Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672696 [TBL] [Abstract][Full Text] [Related]
16. Retinal pathology as biomarker for cognitive impairment and Alzheimer's disease. Ikram MK; Cheung CY; Wong TY; Chen CP J Neurol Neurosurg Psychiatry; 2012 Sep; 83(9):917-22. PubMed ID: 22733082 [TBL] [Abstract][Full Text] [Related]
17. Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Ewers M; Sperling RA; Klunk WE; Weiner MW; Hampel H Trends Neurosci; 2011 Aug; 34(8):430-42. PubMed ID: 21696834 [TBL] [Abstract][Full Text] [Related]
18. Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study. Pérez-Grijalba V; Romero J; Pesini P; Sarasa L; Monleón I; San-José I; Arbizu J; Martínez-Lage P; Munuera J; Ruiz A; Tárraga L; Boada M; Sarasa M J Prev Alzheimers Dis; 2019; 6(1):34-41. PubMed ID: 30569084 [TBL] [Abstract][Full Text] [Related]
19. Role of inflammatory and hemostatic biomarkers in Alzheimer's and vascular dementia - A pilot study from a tertiary center in Northern India. Vishnu VY; Modi M; Garg VK; Mohanty M; Goyal MK; Lal V; Mittal BR; Prabhakar S Asian J Psychiatr; 2017 Oct; 29():59-62. PubMed ID: 29061429 [TBL] [Abstract][Full Text] [Related]